Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
Clinical trial NCT02636699 · COMPLETED
Trial details
- NCT number
- NCT02636699
- Sponsor
- DBV Technologies
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-08-18
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.